Cardiology is leaving the hospital. Will your outpatient strategy lead or lag?
CMS has already approved diagnostic and interventional cardiology, including PCI, in ASCs. By 2026, additional procedures such as ablations, electrophysiology studies, atherectomy, chronic total occlusion treatment, and PCI in bypass grafts are expected to be added. This shift is accelerating and reshaping cardiovascular care across the board.
Hospitals face revenue risk and physician disaffiliation. Cardiologists are weighing ASC ownership, joint ventures, and compensation shifts, while surgery centers race to build capacity, secure payer coverage, and align with specialists.
This whitepaper outlines what each stakeholder must do — and avoid — to lead in the next phase of outpatient cardiology growth.
Inside you'll find:
Hospitals face revenue risk and physician disaffiliation. Cardiologists are weighing ASC ownership, joint ventures, and compensation shifts, while surgery centers race to build capacity, secure payer coverage, and align with specialists.
This whitepaper outlines what each stakeholder must do — and avoid — to lead in the next phase of outpatient cardiology growth.
Inside you'll find:
- Which procedures have already moved and what CMS is likely to add next
- How to assess readiness across staffing, reimbursement and cath lab investment
- Strategic lessons from orthopedics that hospitals, ASCs and physicians can apply now
Please fill out the form to download the whitepaper.